Review updates to the Acute Disease Quality Initiative (ADQI) guidelines for acute kidney injury (AKI) in cirrhosis and how the guideline recommendations should be applied.

Learning Objectives:

• Define the different etiologies of acute kidney injury (AKI) arising in cirrhosis and how they impact treatment and outcomes

• Describe how to apply the Acute Disease Quality Initiative (ADQI) guideline-recommended vasoconstrictor therapy for patients who meet diagnostic criteria for hepatorenal syndrome/AKI

• Discuss the comprehensive management of patients with multiorgan failure in the ICU and the pathway to liver transplant
   

Earn 1 accredited continuing education (ACE) credit through this complimentary product.

Continuing Education 
ACE release date: March 1, 2025
SCCM Product Code: SWEB25A
ACE expiration date: April 1, 2026
Estimated time for activity completion: 1 hour